← Back to Search

Virtual Education Program for Atrial Fibrillation

N/A

Waitlist Available

Led By Anil Gehi, MD

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patient with diagnosis of non-valvular or valvular atrial fibrillation

Age >/= 18

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 1-year post intervention session 6

Awards & highlights

Study Summary

This trial will assess if a virtual education program for adults with AF can lead to improved quality of life and better self-management.

Who is the study for?

This trial is for adults with atrial fibrillation, either non-valvular or valvular. Participants must be 18 years or older and capable of giving informed consent. It's not open to individuals who are incarcerated.Check my eligibility

What is being tested?

The 'AF at Home' program is being tested to see if it improves quality of life and self-care in people with atrial fibrillation. Participants will attend six hours of virtual education over three weeks and complete questionnaires before and after the program.See study design

What are the potential side effects?

Since this trial involves an educational program rather than a drug, traditional side effects aren't expected. However, participants may experience fatigue or eye strain from screen time during virtual sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with atrial fibrillation not caused by heart valve issues.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 1-year post intervention session 6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 1-year post intervention session 6

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1-year post intervention session 6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change Atrial Fibrillation Effect on Quality-of-life Questionnaire (AFEQT) Score

Secondary outcome measures

Change in Cardiac Anxiety Questionnaire (CAQ)

Change in Confidence in Atrial Fibrillation Management (CALM) Scale

Change in Patient-Reported Outcomes Measurement Information System 29 (PROMIS-29) Global Pain Intensity Scores

+6 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: AF at HomeExperimental Treatment1 Intervention

All recruited participants will participate in the AF at Home educational intervention.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Bristol-Myers Squibb FoundationUNKNOWN

5 Previous Clinical Trials

1,204 Total Patients Enrolled

1 Trials studying Atrial Fibrillation

526 Patients Enrolled for Atrial Fibrillation

Bristol-Myers SquibbIndustry Sponsor

2,638 Previous Clinical Trials

4,128,214 Total Patients Enrolled

72 Trials studying Atrial Fibrillation

1,647,068 Patients Enrolled for Atrial Fibrillation

University of North Carolina, Chapel HillLead Sponsor

1,504 Previous Clinical Trials

4,187,362 Total Patients Enrolled

3 Trials studying Atrial Fibrillation

755 Patients Enrolled for Atrial Fibrillation

Media Library

AF at Home Clinical Trial Eligibility Overview. Trial Name: NCT05810896 — N/A

Atrial Fibrillation Research Study Groups: AF at Home

Atrial Fibrillation Clinical Trial 2023: AF at Home Highlights & Side Effects. Trial Name: NCT05810896 — N/A

AF at Home 2023 Treatment Timeline for Medical Study. Trial Name: NCT05810896 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment period for this trial still open?

"This particular trial is no longer looking for volunteers, as evidenced on clinicaltrials.gov where the research was initially posted on April 1st 2023 and subsequently modified on March 30th of the same year. Fortunately, there are an abundance of other ongoing studies that still require participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)

2023. "AF at Home: A Virtual Education Program for Patients With Atrial Fibrillation (AF)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05810896.

All > Afib > Atrial Fibrillation